P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis

POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM:   OBJECTIVE: This case series describes our experience of using isavuconazole (ISVCZ), along with TDM, after the failure of treatment with Amphotericin B (AmB) and Posaconazole (PCZ) due to the better PK PD properties of ISVCZ. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Soman, Rajeev, Chakraborty, Sourabh, Joe, Geethu, Purandare, Bharat, Joshi, Rasika, Patwardhan, Sampada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541475/
http://dx.doi.org/10.1093/mmy/myac072.P173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541475/
http://dx.doi.org/10.1093/mmy/myac072.P173

Ejemplares similares